Alkermes plc.
ALKS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
Since 2021-01-01, last confirmed 2024-04-15
Emily Peterson Alva
Equibles does not estimate personal net worth.
About Emily Peterson Alva
Emily Peterson Alva was last confirmed as Board Member at Alkermes plc. (ALKS) in a filing dated April 15, 2024. Earlier roles on record: Board Member at Amneal Pharmaceuticals, Inc. (AMRX) until July 16, 2025. Amneal Pharmaceuticals, Inc. reported in an 8-K filed July 21, 2025 that Emily Peterson Alva resigned as Member of the Board of Directors and Audit Committee, effective July 16, 2025. Alkermes plc. reported in an 8-K filed May 31, 2024 that Emily Peterson Alva was appointed director, effective May 31, 2024. Alkermes plc. reported in an 8-K filed July 7, 2022 that Emily Peterson Alva was appointed Class II director, effective July 7, 2022.
“on July 16, 2025, Emily Peterson Alva, an Amneal Group designee to the Board, informed the Company of her decision to resign from the Board and its Audit Committee, effective immediately.”
“By separate resolutions, shareholders elected the following directors, each to serve for a one-year term expiring at the Company’s 2025 annual general meeting of shareholders, or until their respective successor is elected and shall qualify, with the votes cast as follows:”
Affiliation history
-
2021-01-01–2024-04-15
Last confirmed by a filing; no departure on record
-
Start not stated–2025-07-16
Company network
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member